Rheumatoid arthritis is a condition that causes painful inflammation of several joints in the body. The joint capsule becomes swollen, and the disease can also destroy cartilage and bone as it progresses. Rheumatoid arthritis affects 0.5% to 1% of the world’s population. Up to this point, doctors have used various drugs to slow or stop the progression of the disease. But now, ETH Zurich researchers have developed a therapy that takes the treatment of rheumatoid arthritis in mice to a new level: after receiving the medication, researchers consider the animals to be fully cured.<br><br><a href="https://www.ethz.ch/en/news-and-events/media-information/media-releases/2014/08/curing-arthritis-in-mice.html">READ MORE ON ETH ZURICH</a><br><br>Hemmerle T, Doll F, Neri D: Antibody-based delivery of IL4 to the neovasculature cures mice with arthritis. PNAS, online publication 4 August 2014, doi: <a href="http://dx.doi.org/10.1073/pnas.1402783111">10.1073/pnas.1402783111</a><br>
